There are limited data regarding fibrosis progression in biopsy-proven nonalcoholic fatty liver disease (NAFLD), between people with type 2 diabetes mellitus (T2DM) versus people without T2DM. We assessed the time to fibrosis progression in people with T2DM versus people without T2DM in a large, multicenter, study of people with NAFLD who had paired liver biopsies.